Jeff Yass’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.03M Buy
276,300
+133,800
+94% +$1.77M ﹤0.01% 5027
2026
Q1
$1.96M Buy
142,500
+1,700
+1% +$25.6K ﹤0.01% 6221
2025
Q4
$2.54M Buy
140,800
+130,400
+1,254% +$2.34M ﹤0.01% 5167
2025
Q3
$193K Sell
10,400
-14,100
-58% -$222K ﹤0.01% 11036
2025
Q2
$392K Sell
24,500
-4,200
-15% -$74.9K ﹤0.01% 9736
2025
Q1
$558K Sell
28,700
-57,000
-67% -$1.2M ﹤0.01% 8661
2024
Q4
$1.89M Sell
85,700
-31,400
-27% -$604K ﹤0.01% 5453
2024
Q3
$1.97M Buy
+117,100
New +$1.74M ﹤0.01% 5293
2024
Q2
Sell
-56,500
Closed -$626K 12140
2024
Q1
$626K Buy
+56,500
New +$577K ﹤0.01% 7967
2023
Q4
Sell
-94,100
Closed -$720K 12436
2023
Q3
$720K Sell
94,100
-100,400
-52% -$754K ﹤0.01% 7388
2023
Q2
$1.4M Sell
194,500
-48,000
-20% -$280K ﹤0.01% 5919
2023
Q1
$1.48M Sell
242,500
-36,700
-13% -$199K ﹤0.01% 5841
2022
Q4
$1.22M Buy
279,200
+217,600
+353% +$972K ﹤0.01% 5762
2022
Q3
$241K Buy
+61,600
New +$309K ﹤0.01% 10362
2022
Q2
Sell
-23,800
Closed -$152K 12986
2022
Q1
$152K Sell
23,800
-15,000
-39% -$99.5K ﹤0.01% 11546
2021
Q4
$311K Sell
38,800
-159,400
-80% -$1.5M ﹤0.01% 10407
2021
Q3
$1.83M Buy
+198,200
New +$2.07M ﹤0.01% 6021

Other funds holding CLBT

Jeff Yass's CLBT Position: Q2 2026 in Review

Jeff Yass reduced its Cellebrite (CLBT) stake by 50% in Q2 2026, selling an estimated $675K and leaving 50,564 shares worth $738K. The position accounts for ﹤0.01% of the portfolio, ranked #8976.

Jeff Yass first reported a position in CLBT in Q4 2021 and has held it in 17 quarters since. The position peaked at $5.13M in Q3 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Jeff Yass held 50,564 shares of Cellebrite worth $738K as of Q2 2026.
  • Jeff Yass sold 51,052 Cellebrite shares in Q2 2026, an estimated $675K.
  • Cellebrite made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #8976 holding.
  • Jeff Yass first reported a position in Cellebrite in Q4 2021 and has held it in 17 quarters since.
  • Jeff Yass's Cellebrite position peaked at $5.13M in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.